Jobs at Mineralys Therapeutics, Inc.
Mineralys Therapeutics is a publicly traded, clinical-stage biopharmaceutical company developing lorundrostat, a selective aldosterone synthase inhibitor for hypertension, chronic kidney disease, and related cardio-renal-metabolic diseases driven by dysregulated aldosterone.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 7
No current roles
Clear a filter to see every role.
See all 7 Mineralys Therapeutics, Inc. roles
Free account. Get new Mineralys Therapeutics, Inc. roles by email or push the minute they post.
